FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:AHCY-RPLP1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: AHCY-RPLP1
FusionPDB ID: 3072
FusionGDB2.0 ID: 3072
HgeneTgene
Gene symbol

AHCY

RPLP1

Gene ID

191

6176

Gene nameadenosylhomocysteinaseribosomal protein lateral stalk subunit P1
SynonymsSAHH|adoHcyaseLP1|P1|RPP1
Cytomap

20q11.22

15q23

Type of geneprotein-codingprotein-coding
DescriptionadenosylhomocysteinaseS-adenosyl-L-homocysteine hydrolaseS-adenosylhomocysteine hydrolaseepididymis secretory sperm binding protein60S acidic ribosomal protein P1acidic ribosomal phosphoprotein P1large ribosomal subunit protein P1ribosomal protein, large, P1
Modification date2020032020200313
UniProtAcc

Q96HN2

Main function of 5'-partner protein: FUNCTION: May regulate the electrogenic sodium/bicarbonate cotransporter SLC4A4 activity and Mg(2+)-sensitivity. On the contrary of its homolog AHCYL1, does not regulate ITPR1 sensitivity to inositol 1,4,5-trisphosphate (PubMed:19220705). {ECO:0000250|UniProtKB:A6QLP2, ECO:0000269|PubMed:19220705}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000217426, ENST00000538132, 
ENST00000468908, 
ENST00000357790, 
ENST00000560274, ENST00000260379, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score9 X 9 X 4=32419 X 14 X 8=2128
# samples 921
** MAII scorelog2(9/324*10)=-1.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(21/2128*10)=-3.34103691783507
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: AHCY [Title/Abstract] AND RPLP1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: AHCY [Title/Abstract] AND RPLP1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AHCY(32883201)-RPLP1(69745986), # samples:1
Anticipated loss of major functional domain due to fusion event.AHCY-RPLP1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
AHCY-RPLP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
AHCY-RPLP1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
AHCY-RPLP1 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:32883201/chr15:69745986)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across AHCY (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RPLP1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000217426AHCYchr2032883201-ENST00000260379RPLP1chr1569745986+97929778569163

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000217426ENST00000260379AHCYchr2032883201-RPLP1chr1569745986+0.0016174140.99838257

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for AHCY-RPLP1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
AHCYchr2032883201RPLP1chr156974598629773AVLIETLVTLGAEEDKINALIKAAGV

Top

Potential FusionNeoAntigen Information of AHCY-RPLP1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AHCY-RPLP1_32883201_69745986.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AHCY-RPLP1chr2032883201chr1569745986297HLA-B50:02AEEDKINA0.99980.58731119
AHCY-RPLP1chr2032883201chr1569745986297HLA-B45:01AEEDKINA0.99970.83281119
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:01EEDKINAL0.99450.96351220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:01AEEDKINA0.98880.93771119
AHCY-RPLP1chr2032883201chr1569745986297HLA-B13:01AEEDKINAL0.99590.91521120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B50:02AEEDKINAL0.99450.58421120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B47:01AEEDKINAL0.97740.66011120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:03AEEDKINAL0.97480.96871120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B45:01AEEDKINAL0.97320.82431120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:03EEDKINALI0.9730.95551221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B45:01EEDKINALI0.96710.71541221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:13AEEDKINAL0.80520.95241120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:01AEEDKINAL0.76140.96141120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:01AEEDKINAL0.72750.97461120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B50:01AEEDKINAL0.53030.68511120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:01AEEDKINAL0.51670.9091120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B45:01AEEDKINALI0.95660.82881121
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:13GAEEDKINAL0.67130.95411020
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:01AEEDKINALI0.66880.91271121
AHCY-RPLP1chr2032883201chr1569745986297HLA-B45:01EEDKINALIKA0.99930.63331223
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:08EEDKINAL0.99770.7341220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B40:06AEEDKINAL0.99970.62941120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:08AEEDKINAL0.87850.8271120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B14:03AEEDKINAL0.79410.88591120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:09AEEDKINAL0.77820.67761120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:05AEEDKINAL0.76940.95371120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:12AEEDKINAL0.72660.9641120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:08EEDKINALI0.43790.75311221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:08GAEEDKINAL0.93630.84881020
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:08AEEDKINALI0.8050.87161121
AHCY-RPLP1chr2032883201chr1569745986297HLA-B40:04EEDKINAL0.99950.66811220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:11EEDKINAL0.99720.69411220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:31EEDKINAL0.99660.93261220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:05EEDKINAL0.99450.96351220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:06EEDKINAL0.99390.96431220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:08EEDKINAL0.99340.92941220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:03EEDKINAL0.99270.95961220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:11EEDKINAL0.98540.91131220
AHCY-RPLP1chr2032883201chr1569745986297HLA-B40:04AEEDKINAL0.99970.71481120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B40:04EEDKINALI0.9860.69011221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:13AEEDKINAL0.97480.96871120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:07AEEDKINAL0.97480.96871120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:26AEEDKINAL0.97480.96871120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:13EEDKINALI0.9730.95551221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:07EEDKINALI0.9730.95551221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B44:26EEDKINALI0.9730.95551221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:11AEEDKINAL0.86130.79831120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:03AEEDKINAL0.82880.5031120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:11AEEDKINAL0.82250.96121120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:02AEEDKINAL0.78660.95731120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:31AEEDKINAL0.7650.96091120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:05AEEDKINAL0.72750.97461120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:08AEEDKINAL0.68280.95121120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B18:03AEEDKINAL0.63680.9721120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:03EEDKINALI0.60180.52461221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B50:04AEEDKINAL0.53030.68511120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B50:05AEEDKINAL0.53030.68511120
AHCY-RPLP1chr2032883201chr1569745986297HLA-B39:11EEDKINALI0.39130.72431221
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:03AEEDKINALI0.72340.58721121
AHCY-RPLP1chr2032883201chr1569745986297HLA-B40:04GAEEDKINAL0.6890.71991020
AHCY-RPLP1chr2032883201chr1569745986297HLA-B41:03GAEEDKINAL0.64290.52921020

Top

Potential FusionNeoAntigen Information of AHCY-RPLP1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AHCY-RPLP1_32883201_69745986.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0442AVLIETLVTLGAEED015
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0453AVLIETLVTLGAEED015
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0456AVLIETLVTLGAEED015
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0802AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0804AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0806AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0809AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0810AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0812AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0813AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0820AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0821AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0822AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0824AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0828AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-0831AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1002IETLVTLGAEEDKIN318
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1101AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1104AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1105AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1106AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1109AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1110AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1112AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1113AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1115AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1118AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1124AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1125AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1128AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1129AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1132AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1133AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1134AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1135AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1137AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1138AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1139AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1142AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1143AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1144AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1146AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1147AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1149AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1150AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1151AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1154AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1156AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1157AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1158AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1160AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1161AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1162AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1166AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1167AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1172AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1174AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1175AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1177AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1178AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1180AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1181AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1183AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1184AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1187AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1188AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1189AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1190AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1191AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1192AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1194AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1195AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1196AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1204AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1209AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1305AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1306AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1307AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1311AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1314AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1318AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1326AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1342AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1344AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1347AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1350AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1362AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1406AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1412AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1415AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1417AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1420AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1427AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1429AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1434AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1452AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1473AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1474AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1478AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1480AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1481AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1483AEEDKINALIKAAGV1126
AHCY-RPLP1chr2032883201chr1569745986297DRB1-1484AEEDKINALIKAAGV1126

Top

Fusion breakpoint peptide structures of AHCY-RPLP1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5800LVTLGAEEDKINALAHCYRPLP1chr2032883201chr1569745986297

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of AHCY-RPLP1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5800LVTLGAEEDKINAL-7.15543-7.26883
HLA-B14:023BVN5800LVTLGAEEDKINAL-4.77435-5.80965
HLA-B52:013W395800LVTLGAEEDKINAL-6.80875-6.92215
HLA-B52:013W395800LVTLGAEEDKINAL-4.20386-5.23916
HLA-A11:014UQ25800LVTLGAEEDKINAL-7.5194-8.5547
HLA-A11:014UQ25800LVTLGAEEDKINAL-6.9601-7.0735
HLA-A24:025HGA5800LVTLGAEEDKINAL-7.52403-7.63743
HLA-A24:025HGA5800LVTLGAEEDKINAL-5.82433-6.85963
HLA-B27:056PYJ5800LVTLGAEEDKINAL-3.28285-4.31815
HLA-B44:053DX85800LVTLGAEEDKINAL-5.91172-6.94702
HLA-B44:053DX85800LVTLGAEEDKINAL-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of AHCY-RPLP1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
AHCY-RPLP1chr2032883201chr15697459861020GAEEDKINALGGTGCTGAGGAGGATAAGATCAATGCCCTC
AHCY-RPLP1chr2032883201chr15697459861119AEEDKINAGCTGAGGAGGATAAGATCAATGCC
AHCY-RPLP1chr2032883201chr15697459861120AEEDKINALGCTGAGGAGGATAAGATCAATGCCCTC
AHCY-RPLP1chr2032883201chr15697459861121AEEDKINALIGCTGAGGAGGATAAGATCAATGCCCTCATT
AHCY-RPLP1chr2032883201chr15697459861220EEDKINALGAGGAGGATAAGATCAATGCCCTC
AHCY-RPLP1chr2032883201chr15697459861221EEDKINALIGAGGAGGATAAGATCAATGCCCTCATT
AHCY-RPLP1chr2032883201chr15697459861223EEDKINALIKAGAGGAGGATAAGATCAATGCCCTCATTAAAGCA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
AHCY-RPLP1chr2032883201chr1569745986015AVLIETLVTLGAEEDGCCGTCCTCATTGAGACCCTCGTCACCCTGGGTGCTGAGGAGGAT
AHCY-RPLP1chr2032883201chr15697459861126AEEDKINALIKAAGVGCTGAGGAGGATAAGATCAATGCCCTCATTAAAGCAGCCGGTGTA
AHCY-RPLP1chr2032883201chr1569745986318IETLVTLGAEEDKINATTGAGACCCTCGTCACCCTGGGTGCTGAGGAGGATAAGATCAAT

Top

Information of the samples that have these potential fusion neoantigens of AHCY-RPLP1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
COADAHCY-RPLP1chr2032883201ENST00000217426chr1569745986ENST00000260379TCGA-A6-6648-01A

Top

Potential target of CAR-T therapy development for AHCY-RPLP1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to AHCY-RPLP1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to AHCY-RPLP1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource